Inhibitors Under Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inhibitors Under Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inhibitors Under Development Today - Breaking & Trending Today

PRMT5 Inhibitors Plus Antiestrogens May Combat Resistance to CDK4/6 Inhibitors in ER+ Breast Cancer

Published: March 9, 2024

PRMT5 inhibitors with antiestrogens represents a therapeutic strategy that may overcome resistance to CDK4/6 inhibitors in ER+/RB-deficient breast cancer.

Source: onclive.com

Related Topics:

United StatesMemorial Sloan Kettering Cancer CenterNew YorkCarlosl ArteagaSimmons Comprehensive Cancer CenterBreast Cancer ResearchInhibitors Under DevelopmentAnnette Simmons Distinguished UniversityUt Southwestern Medical CenterInterdisciplinary Prostate Cancer CongressAnnual Miami Breast Cancer ConferenceOncology ProgramsMedical CenterAnnette Simmons Distinguished University ChairBreast CancerAnnual Interdisciplinary Prostate Cancer CongressPractice Guidelines